Yigal Nochomovitz

Stock Analyst at Citigroup

(3.39)
# 967
Out of 5,072 analysts
327
Total ratings
43.3%
Success rate
4.64%
Average return

Stocks Rated by Yigal Nochomovitz

ORIC Pharmaceuticals
Nov 17, 2025
Maintains: Buy
Price Target: $12$16
Current: $11.85
Upside: +35.02%
Candel Therapeutics
Nov 14, 2025
Maintains: Buy
Price Target: $25$24
Current: $4.77
Upside: +403.14%
Arcturus Therapeutics Holdings
Nov 13, 2025
Maintains: Neutral
Price Target: $12$9
Current: $6.79
Upside: +32.55%
CRISPR Therapeutics AG
Nov 12, 2025
Maintains: Buy
Price Target: $87$77
Current: $53.47
Upside: +44.01%
ArriVent BioPharma
Nov 11, 2025
Maintains: Buy
Price Target: $33$31
Current: $22.98
Upside: +34.90%
Biomea Fusion
Nov 10, 2025
Maintains: Buy
Price Target: $7$6
Current: $1.09
Upside: +450.46%
BeOne Medicines AG
Nov 10, 2025
Maintains: Buy
Price Target: $399$405
Current: $340.61
Upside: +18.90%
Solid Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $16$14
Current: $5.43
Upside: +157.83%
Krystal Biotech
Nov 4, 2025
Maintains: Neutral
Price Target: $166$198
Current: $218.00
Upside: -9.17%
Ardelyx
Nov 3, 2025
Maintains: Buy
Price Target: $10$11
Current: $5.82
Upside: +89.17%
Maintains: Buy
Price Target: $5$8
Current: $1.94
Upside: +312.37%
Maintains: Buy
Price Target: $52$45
Current: $21.32
Upside: +111.12%
Maintains: Buy
Price Target: $54$56
Current: $26.10
Upside: +114.56%
Maintains: Buy
Price Target: $175$203
Current: $152.16
Upside: +33.41%
Maintains: Buy
Price Target: $27$46
Current: $38.83
Upside: +18.47%
Initiates: Buy
Price Target: $33
Current: $25.04
Upside: +31.79%
Maintains: Buy
Price Target: $35$40
Current: $17.89
Upside: +123.59%
Downgrades: Neutral
Price Target: $101$97
Current: $96.14
Upside: +0.89%
Maintains: Buy
Price Target: $20$21
Current: $28.32
Upside: -25.85%
Maintains: Buy
Price Target: $66$69
Current: $20.41
Upside: +238.07%
Maintains: Buy
Price Target: $19$22
Current: $26.71
Upside: -17.63%
Maintains: Buy
Price Target: $1.2$1.9
Current: $1.43
Upside: +32.87%
Maintains: Buy
Price Target: $46$51
Current: $19.82
Upside: +157.32%
Maintains: Buy
Price Target: $49$52
Current: $30.38
Upside: +71.17%
Initiates: Sell
Price Target: $7
Current: $21.34
Upside: -67.20%
Maintains: Buy
Price Target: $6$9
Current: $2.22
Upside: +305.41%
Maintains: Neutral
Price Target: $10$9.5
Current: $12.59
Upside: -24.51%
Maintains: Buy
Price Target: $49$55
Current: $50.49
Upside: +8.93%
Initiates: Buy
Price Target: $33
Current: $14.80
Upside: +122.97%
Maintains: Buy
Price Target: $13$8
Current: $0.26
Upside: +2,976.92%
Downgrades: Neutral
Price Target: $8$2
Current: $2.08
Upside: -3.85%
Maintains: Buy
Price Target: $60$58
Current: $35.58
Upside: +63.01%
Maintains: Buy
Price Target: $16$14
Current: $1.53
Upside: +815.03%
Maintains: Neutral
Price Target: $3.5$1.2
Current: $1.78
Upside: -32.58%
Maintains: Neutral
Price Target: $1.8$2
Current: $2.34
Upside: -14.53%
Maintains: Buy
Price Target: $25$8
Current: $5.49
Upside: +45.72%
Maintains: Neutral
Price Target: $1.5$1
Current: $5.51
Upside: -81.85%
Maintains: Sell
Price Target: $50$35
Current: $14.70
Upside: +138.10%
Maintains: Buy
Price Target: $130$133
Current: $34.75
Upside: +282.73%
Maintains: Buy
Price Target: $24$16
Current: $5.08
Upside: +214.96%
Maintains: Buy
Price Target: $9$10
Current: $1.14
Upside: +777.19%
Maintains: Buy
Price Target: $16$12
Current: $1.95
Upside: +515.38%
Upgrades: Buy
Price Target: n/a
Current: $5.05
Upside: -